0
0

Medicare Outpatient Prescription Drug Act of 2002

1/16/2023, 2:47 AM

Congressional Summary of S 2625

Medicare Outpatient Prescription Drug Act of 2002 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to establish: (1) a Medicare Outpatient Prescription Drug Benefit Program under new part D; (2) a Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund; and (3) a Medicare Prescription Drug Advisory Committee.

Provides for: (1) part D benefits under Medicare+Choice plans under Medicare part C (Medicare+Choice); and (2) Medicare cost-sharing and other assistance for low-income individuals but only as it relates to benefits provided under new part D.

Revises Medicare supplemental insurance policy (Medigap) benefit packages to conform to changes made by this Act, eliminating obsolete policies with no grandfathering.

Directs the Secretary of Health and Human Services to study and report to Congress on the feasibility and advisability of: (1) establishing a uniform format for pharmacy benefit cards provided to beneficiaries; and (2) developing systems to transfer electronically prescriptions under such program from the prescriber to the pharmacist.

Requires the Comptroller General to conduct an ongoing study and analysis of the program established under this Act, especially: (1) the extent to which the competitive bidding process under it fosters maximum competition and efficiency; and (2) the savings to the Medicare program resulting from it, including the reduction in the number or length of hospital visits.

Expands the membership and duties of the Medicare Payment Advisory Commission (MEDPAC).

Read the Full Bill

Current Status of Bill S 2625

Bill S 2625 is currently in the status of Bill Introduced since June 14, 2002. Bill S 2625 was introduced during Congress 107 and was introduced to the Senate on June 14, 2002.  Bill S 2625's most recent activity was Sponsor introductory remarks on measure. (CR S5792) as of June 20, 2002

Bipartisan Support of Bill S 2625

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
30
Democrat Cosponsors
30
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2625

Primary Policy Focus

Health

Potential Impact Areas

- Access to health care
- Administrative procedure
- Administrative remedies
- Advertising
- Allergies
- Ambulatory care
- Auditing
- Capitation (Medical care)
- Civil Rights and Liberties, Minority Issues
- Coinsurance
- Commerce
- Communication in medicine
- Competition
- Competitive bidding
- Conflict of interests
- Congress
- Congressional investigations
- Congressional reporting requirements
- Consumer education
- Consumer organizations
- Cost control
- Cost effectiveness
- Department of Health and Human Services
- Drug abuse
- Drug industry
- Drug interactions
- Drug therapy
- Drug utilization
- Drugs
- Economics and Public Finance
- Electronic data interchange
- Emergency Management
- Emergency medicine
- Employee health benefits
- Executive reorganization
- Federal advisory bodies
- Federal aid to territories
- Federal employees
- Federal officials
- Finance and Financial Sector
- Fines (Penalties)
- Generic drugs
- Government Operations and Politics
- Government employees' health insurance
- Government paperwork
- Government publicity
- Government trust funds
- Governmental investigations
- Health insurance
- Health insurance continuation
- Health maintenance organizations
- Housing and Community Development
- Identification devices
- Immunosuppressive drugs
- Indexing (Economic policy)
- Insulin
- Insurance premiums
- Insurance rates
- Labor and Employment
- Law
- Legislation
- Licenses
- Managed care
- Marketing
- Medicaid
- Medical economics
- Medical malpractice
- Medical records
- Medically uninsured
- Medicare
- Medicare Payment Advisory Commission
- Medicare fraud
- Medicare managed care
- Medigap
- Nonprescription drugs
- Nonprofit organizations
- Patient satisfaction
- Performance measurement
- Pharmaceutical research
- Pharmacies
- Pharmacists
- Prescription pricing
- Quality of care
- Rebates
- Research and development
- Retiree health benefits
- Right of privacy
- Rural health
- Science, Technology, Communications
- Social Welfare
- Standards
- Subsidies
- Surveys
- Transplantation of organs, tissues, etc.
- Urban affairs
- Urban areas

Alternate Title(s) of Bill S 2625

Medicare Outpatient Prescription Drug Act of 2002
A bill to amend title XVIII of the Social Security Act to provide coverage of outpatient prescription drugs under the medicare program.
Medicare Outpatient Prescription Drug Act of 2002
Medicare Prescription Drug Benefit bill

Comments